OGC
ABUS icon

One68 Global Capital’s Arbutus Biopharma ABUS Stock Holding History

One68 Global Capital’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$113K Buy
+31,880
New +$112K 0.23% 98

Other funds holding ABUS

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Think Investments San Francisco, California $762M AUM 33.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

One68 Global Capital's ABUS Position: Q4 2020 in Review

One68 Global Capital opened a new position in Arbutus Biopharma (ABUS) in Q4 2020: 31,880 shares worth $113K. The stake represents 0.23% of the portfolio and ranks #98 among its holdings.

80 funds tracked by Wall St. Rank hold ABUS as of Q4 2020.

  • One68 Global Capital held 31,880 shares of Arbutus Biopharma worth $113K as of Q4 2020.
  • Arbutus Biopharma was a new One68 Global Capital position in Q4 2020.
  • Arbutus Biopharma made up 0.23% of One68 Global Capital's portfolio in Q4 2020, its #98 holding.
  • 80 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2020.

Based on One68 Global Capital's 13F filing for Q4 2020, filed 16 Feb 2021.